HDAC9 and glioblastoma: Here, we evaluated whether different histone deacetylase inhibitors, with different selectivity for HDAC classes, are able to impair GBM cell line and GBM CSCs capability to form tube-like structure on extracellular matrix (ECM) in vitro, as model of vasculogenic mimicry.